Bicycle Therapeutics plc Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Bicycle Therapeutics plc stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $7.00K.
- Bicycle Therapeutics plc stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $912.00K, a 556.12% increase year-over-year.
- Bicycle Therapeutics plc stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $4.50M, a 2627.27% increase year-over-year.
- Bicycle Therapeutics plc stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $1.87M, a 186900.00% increase year-over-year.
- Bicycle Therapeutics plc stock issued during period, value, stock options exercised for fiscal 2025 was $33.00K, a 99.56% decline from fiscal 2024.
- Bicycle Therapeutics plc stock issued during period, value, stock options exercised for fiscal 2024 was $7.53M, a 1005.29% increase from fiscal 2023.
- Bicycle Therapeutics plc stock issued during period, value, stock options exercised for fiscal 2023 was $681.00K, a 31.14% decline from fiscal 2022.
- Bicycle Therapeutics plc stock issued during period, value, stock options exercised for fiscal 2022 was $989.00K, a 86.23% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $7.00K 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $33.00K 10-K · filed 2026-03-17 | |
| 2024-12-31 | $7.53M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $912.00K 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $4.50M 10-Q · filed 2025-10-30 | |
| 2024-03-31 | $1.87M 10-Q · filed 2025-10-30 | |
| 2023-12-31 | $681.00K 10-K · filed 2026-03-17 | |
| 2023-09-30 | $139.00K 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $165.00K 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $1.00K 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $989.00K 10-K · filed 2025-02-25 | |
| 2022-09-30 | $159.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $195.00K 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $450.00K 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $7.18M 10-K · filed 2024-02-20 | |
| 2021-09-30 | $3.05M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $1.57M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $284.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $271.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $87.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $9.00K 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $2.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $143.00K 10-K · filed 2022-03-01 | |
| 2019-06-30 | $21.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |